Kynam Capital Management, LP Liquidia Corp Transaction History
Kynam Capital Management, LP
- $953 Million
- Q1 2024
A detailed history of Kynam Capital Management, LP transactions in Liquidia Corp stock. As of the latest transaction made, Kynam Capital Management, LP holds 2,248,324 shares of LQDA stock, worth $27 Million. This represents 3.48% of its overall portfolio holdings.
Number of Shares
2,248,324
Previous 2,698,324
16.68%
Holding current value
$27 Million
Previous $32.5 Million
2.16%
% of portfolio
3.48%
Previous 3.63%
Shares
9 transactions
Others Institutions Holding LQDA
# of Institutions
157Shares Held
35.5MCall Options Held
1.68MPut Options Held
1.17M-
Patient Square Capital LP Menlo Park, CA7.18MShares$86.2 Million45.11% of portfolio
-
Black Rock Inc. New York, NY3.75MShares$45 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.89MShares$34.6 Million0.0% of portfolio
-
Findell Capital Management LLC New York, NY2.11MShares$25.3 Million16.28% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.06MShares$24.7 Million0.14% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $772M
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...